<?xml version="1.0" encoding="UTF-8"?>
<ref id="R90">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Öhrfelt</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Brinkmalm</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Dumurgier</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Brinkmalm</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Hansson</surname>
   <given-names>O</given-names>
  </name>, 
  <name>
   <surname>Zetterberg</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Bouaziz-Amar</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Hugon</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Paquet</surname>
   <given-names>C</given-names>
  </name>, and 
  <name>
   <surname>Blennow</surname>
   <given-names>K</given-names>
  </name> (
  <year>2016</year>). 
  <article-title>The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease</article-title>. 
  <source>Alzheimers Res. Ther</source>
  <volume>8</volume>, 
  <fpage>41</fpage>.
  <pub-id pub-id-type="pmid">27716408</pub-id>
 </mixed-citation>
</ref>
